A novel mutation of the erythropoietin receptor gene associated with primary familial and congenital polycythaemia

Int J Hematol. 2011 Apr;93(4):542-544. doi: 10.1007/s12185-011-0813-z. Epub 2011 Mar 25.

Abstract

Primary familial and congenital polycythaemia (PFCP) is a rare form of inherited erythrocytosis caused by heterozygous mutations in the erythropoietin receptor gene (EPOR). We present a novel mutation in the EPOR in a 15-year-old male who was referred to our clinic for investigation of a persistently elevated haemoglobin level. A significant family history of unexplained erythrocytosis spanning four generations of the patient's family was established. The family history was also significant for an apparent increased rate of cerebrovascular disease in individuals with erythrocytosis. The mutation detected in our patient resides in exon 8 of EPOR, similar to all other EPOR mutations responsible for PFCP. These mutations result in truncation of the cytoplasmic domain of the receptor and impair down-regulation of signalling via the erythropoietin receptor (EPOR). Clinical manifestations in published cases have varied widely and there is a paucity of firm recommendations regarding the management of affected patients. Given the strong family history of complications attributable to erythrocytosis we have recommended venesection with a haematocrit target of ≤0.45 for our patient.

Publication types

  • Case Reports

MeSH terms

  • Frameshift Mutation*
  • Humans
  • Male
  • Pedigree
  • Polycythemia / genetics*
  • Receptors, Erythropoietin / genetics*
  • Young Adult

Substances

  • Receptors, Erythropoietin